Zobrazeno 1 - 6
of 6
pro vyhledávání: '"DAPA-CKD Trial Committees and Investigators"'
Autor:
the DAPA-CKD Trial Committees and Investigators, Hiddo J.L. Heerspink, David C. Wheeler, Anna Maria Langkilde, Robert D. Toto, Bergur V. Stefansson, Harpreet S. Bajaj, Ricardo Correa-Rotter, John J.V. McMurray, Niels Jongs, Fan Fan Hou, Glenn M. Chertow, Priya Vart, Peter Rossing, Frederik Persson
Objective DAPA-CKD demonstrated risk reduction for kidney and cardiovascular outcomes with dapagliflozin versus placebo in participants with chronic kidney disease (CKD) with and without diabetes. We compared outcomes according to baseline glycemic s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34360c61c8585d8e32e1e15d4074a767
https://doi.org/10.2337/figshare.14465844.v1
https://doi.org/10.2337/figshare.14465844.v1
Autor:
Chertow G, Vart P, Jongs N, Toto R, Gorriz J, Hou F, McMurray J, Correa-Rotter R, Rossing P, Sjostrom C, Stefansson B, Langkilde A, Wheeler D, Heerspink H, DAPA-CKD Trial Committees and Investigators
Publikováno v:
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
BACKGROUND: In the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized, placebo-controlled trial, the sodium-glucose cotransporter 2 inhibitor dapagliflozin significantly reduced risk of kidney failure and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::1846c91c889e5765ecd50b8baf286113
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=15969
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=15969
Autor:
Heerspink H, Sjostrom C, Jongs N, Chertow G, Kosiborod M, Hou F, McMurray J, Rossing P, Correa-Rotter R, Kurlyandskaya R, Stefansson B, Toto R, Langkilde A, Wheeler D, DAPA-CKD Trial Comm Investigators, DAPA-CKD Trial Committees and Investigators
Publikováno v:
EUROPEAN HEART JOURNAL
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Aims Mortality rates from chronic kidney disease (CKD) have increased in the last decade. In this pre-specified analysis of the DAPA-CKD trial, we determined the effects of dapagliflozin on cardiovascular and non-cardiovascular causes of death. Metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::a798bbbbab093d51c9c212bc41983b5b
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=16162
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=16162
Autor:
Persson, Frederik, Rossing, Peter, Vart, Priya, Chertow, Glenn M., Hou, Fan Fan, Jongs, Niels, McMurray, John J.V., Correa-Rotter, Ricardo, Bajaj, Harpreet S., Stefansson, Bergur V., Toto, Robert D., Langkilde, Anna Maria, Wheeler, David C., Heerspink, Hiddo J.L., DAPA-CKD Trial Committees and Investigators
Publikováno v:
Diabetes Care; Aug2021, Vol. 44 Issue 8, p1894-1897, 4p
Autor:
McMurray, John J. V., Wheeler, David C., Stefánsson, Bergur V., Jongs, Niels, Postmus, Douwe, Correa-Rotter, Ricardo, Chertow, Glenn M., Greene, Tom, Held, Claes, Hou, Fan-Fan, Mann, Johannes F. E., Rossing, Peter, Sjöström, C. David, Toto, Roberto D., Langkilde, Anna Maria, Heerspink, Hiddo J. L., DAPA-CKD Trial Committees and Investigators
Publikováno v:
Circulation; 2/2/2021, Vol. 143 Issue 5, p438-448, 11p
Autor:
Heerspink, Hiddo J. L.1,2 h.j.lambers.heerspink@umcg.nl, Stefánsson, Bergur V.3, Correa-Rotter, Ricardo4, Chertow, Glenn M.5, Greene, Tom6, Fan-Fan Hou7, Mann, Johannes F. E.8, McMurray, John J. V.9, Lindberg, Magnus3, Rossing, Peter8, Sjöström, C. David3, Toto, Roberto D.10, Langkilde, Anna-Maria3, Wheeler, David C.2, Hou, Fan-Fan11, DAPA-CKD Trial Committees and Investigators
Publikováno v:
New England Journal of Medicine. 10/8/2020, Vol. 383 Issue 15, p1436-1446. 11p.